# Rivastigmine Tartrate

NDC: 65862-649
Generic name: Rivastigmine Tartrate
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20160325

FDA application: ANDA204572

## Active ingredients

- RIVASTIGMINE TARTRATE: 3 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65862-649"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65862-649
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c246a0e5-1e77-41ee-a7b3-384f21f2f2e0